A study to evaluate the efficacy and safety of JS002 in patients with heterozygous familial hypercholesterolemia (HeFH)
| Title | A study to evaluate the efficacy and safety of JS002 in patients with heterozygous familial hypercholesterolemia (HeFH) |
|---|---|
| Description | Heterozygous familial hypercholesterolemia (HeFH) is a prevalent autosomal dominant disorder of lipid metabolism but severely underdiagnosed and undertreated in China. This phase 3 trial aims to evaluate the efficacy and safety of ongericimab, a novel monoclonal antibody that targets proprotein convertase subtilisin/kexin type 9 (PCSK9), in Chinese patients with HeFH |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA024566 |
| Release Date | 2024-06-28 |
| Submitter | Yu Hao (yu_hao@junshipharma.com) |
| Organization | Shanghai Junshi Biosciences Co., Ltd. |
| Submission Date | 2024-03-22 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX006050-02 | Gene data | 1 | Other Type of Genomic Data | 2.4 MB | xlsx | 0 | Controlled |